Masimo Announces FDA 510(k) Clearance of Radius Tº™ for Prescription and Over-the-Counter (OTC) Use
The Radius Tº Wearable Continuous Body Temperature Thermometer Is Now Available for Use in Hospital and at Home IRVINE, Calif.--(BUSINESS...
News
NextGen® Revenue Cycle Management Services Adopted by Palmetto Retina Center
Leading Eyecare and Surgery Center Leveraging Managed Services to Improve Financial Performance and Enhance Patient Experience ATLANTA--(BUSINESS WIRE)--$NXGN #AmbulatoryHealthcare--NextGen Healthcare,...
Digital Innovation Is Essential to Meeting Healthcare Consumers’ Expectations Post-Pandemic, According to Accenture Report
Accenture’s Digital Health Technology Vision 2021 notes the importance of cloud technology and human ingenuity for the future of healthcare...
Inogen Announces Appointment of General Counsel
- Jason Somer to join as Executive Vice President and General Counsel Effective July 12, 2021 - GOLETA, Calif.--(BUSINESS WIRE)--Inogen,...
Pharnext: Shareholder Letter
PARIS, FRANCE / ACCESSWIRE / June 21, 2021 / Pharnext SA (FR0011191287 - ALPHA), an advanced late-stage clinical biopharmaceutical company...
Love Hemp Group PLC Announces Endorsement Agreement Secured with Anthony Joshua
Three-Year Endorsement Agreement Secured with Anthony Joshua OBEHeavyweight Champion of the World and Olympic Gold Medallist to Become Key ShareholderLONDON,...
Relief Announces the Results of the Annual General Meeting 2021 of RELIEF THERAPEUTICS Holding AG: All Proposals Approved by a Large Majority
GENEVA, SWITZERLAND / June 21, 2021 / RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) (" Relief " or the...
New Psychedelic Drug Formula Believed to Work to Mitigate Neurological Damage Due to Stroke, Provisional Patent Application Filed
VANCOUVER, British Columbia, June 19, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN:...
Disabilities Special Needs Dentist Duncanville Forth Worth TX Updates Services
Disability Dental is now providing an updated range of special needs dentistry services to patients of all ages in Duncanville,...
Invisalign Midtown East NY Clear Aligner Therapy For Teeth Straightening Updated
Modern Dental of Manhattan (+1-212-758-1000) announced that its custom Invisalign clear aligner treatment is now available to patients dealing with...
Biophytis announces new convertible bond financing for up to €32 million with Atlas and drawing of 2 tranches under the 2020 Atlas Contract for €6 million
PARIS and Cambridge, Mass., June 19, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis”...
Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., June 18, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing...
Baudax Bio Announces Special Meeting of Shareholders to Vote on Proposed Increase in Number of Authorized Shares of Common Stock
Special meeting to be held virtually on July 13, 2021, at 9:00 a.m. Eastern TimeMALVERN, Pa., June 18, 2021 (GLOBE...
Tarsus Pharmaceuticals, Inc. Schedules Conference Call and Webcast to Announce Saturn-1 Phase 2b/3 Pivotal Trial Results for TP-03 for the Treatment of Demodex Blepharitis
IRVINE, Calif., June 18, 2021 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission...
TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis at 7th Congress of the European Academy of Neurology
NEW YORK, June 18, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data from the ULTIMATE I...
New Zolgensma data demonstrate age-appropriate development when used presymptomatically and rapid, clinically meaningful efficacy in symptomatic children, even those with severe SMA at baseline
All children (100%) treated presymptomatically in the SPR1NT two-copy cohort survived without respiratory or nutritional support, and sat independently for...
RAPT Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
SOUTH SAN FRANCISCO, Calif., June 18, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused...
HUTCHMED Announces NMPA Approval of Surufatinib (Sulanda® in China) for Advanced Pancreatic Neuroendocrine Tumors
– Second New Drug Application (“NDA”) approved for Sulanda in China – – The pivotal Phase III SANET-p trial demonstrated...
Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders
Scheduled to Reconvene on June 30, 2021Company Urgently Encourages Stockholders to Vote BUENA, N.J., June 18, 2021 (GLOBE NEWSWIRE) --...
Evergreen Therapeutics, Inc. Announces Agreement with ICON plc to Conduct Phase II Clinical Trial for COVID-19 Drug Candidate
Bethesda, Maryland , June 18, 2021 (GLOBE NEWSWIRE) -- Evergreen Therapeutics, Inc. (“Evergreen,” or the “Company”), a fast-growing clinical stage...